| 07.27.16

Phosphorus and the Rise of the New Genomics Startup

By Matt Turck

FirstMark’s Matt Turck reflects on his newest investment in Phosphorus, and what it may mean for the present and future of genomics startups:

As we are perhaps reaching the end of a cycle of innovation in tech – the one that resulted from the simultaneous emergence of social, mobile and cloud – and collectively pondering what’s next, one of the areas I’ve found particularly exciting recently is the intersection of Big Data and life sciences.

A little over two years ago, in connection with my investment in Recombine, a genomics startup, I wrote (here) about another powerful combination of trends: the sharp drop in the cost of sequencing the human genome, the maturation of Big Data technologies, and the increasing commoditization of wet lab work.

Read the full article on